Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/8/2025

Radiation Therapy for Soft Tissue Sarcomas

Introduction to Radiation Therapy

  • The British guidelines recommend adjuvant radiation therapy for patients with a tumor margin of 1 mm, with a safety margin of at least 1-2 cm around the tumor bed, to reduce the risk of local recurrence in patients with soft tissue sarcomas 1
  • Adjuvant radiation therapy is strongly recommended for patients with soft tissue sarcomas and narrow surgical margins (1 mm) to significantly reduce the risk of local recurrence, as supported by the British guidelines for managing soft tissue sarcomas 1

Radiation Therapy Dosage

  • The recommended radiation therapy dosage is 60-66 Gy in fractions of 1.8-2 Gy for post-operative radiation therapy, as suggested by the British guidelines for managing soft tissue sarcomas 1
  • Hypofractionated schemes can be considered, with 25-30 Gy in five fractions over one week, as recommended by the British guidelines for managing soft tissue sarcomas 1

Factors Influencing Radiation Therapy

  • The presence of other risk factors, such as perineural or lymphovascular invasion, increases the need for adjuvant radiation therapy, according to the Journal of Clinical Oncology 2
  • The anatomical location of the tumor and the histological grade should be considered when planning radiation therapy fields, as recommended by the British guidelines for managing soft tissue sarcomas 1

Diagnosis and Treatment of Rare Neoplasms

  • Proper diagnosis of rare neoplasms, such as Proliferating Pilar Tumors (PPTs) and Phyllodes tumors, is essential before treatment, including clinical presentation, imaging, and histopathological confirmation, as recommended by the National Comprehensive Cancer Network and the British Journal of Cancer 3, 4
  • Wide local excision with ≥1 cm margins is recommended for PPTs and Phyllodes tumors, with complete removal and negative margins critical to prevent recurrence, as supported by the National Comprehensive Cancer Network and the British Journal of Cancer 3, 4, 1

Adjuvant Therapy for Rare Neoplasms

  • Adjuvant radiation therapy is strongly recommended for all malignant Phyllodes tumors, and considered for borderline Phyllodes with high-risk features, as recommended by the British Journal of Cancer and the National Comprehensive Cancer Network guidelines 1, 4
  • There is no established role for chemotherapy in primary management, but for metastatic disease, follow soft tissue sarcoma protocols, as stated by the British Journal of Cancer and the National Comprehensive Cancer Network guidelines 1, 4

Follow-up and Management of Recurrence

  • Regular clinical follow-up every 3-6 months for the first 2 years and extended follow-up for at least 5 years, particularly for borderline or malignant variants, with imaging studies as clinically indicated, is essential for monitoring recurrence risk, as recommended by the National Comprehensive Cancer Network guidelines 3, 4, 1
  • Local recurrence is managed with re-excision with wide margins without axillary staging, and consideration of postoperative radiation if not previously administered, as recommended by the National Comprehensive Cancer Network guidelines 4, 1

Surgical Considerations

  • Narrow margins (<1 cm) significantly increase local recurrence risk, and achieving negative margins is the most important factor for local control, as stated by the National Comprehensive Cancer Network guidelines 1
  • Optimal surgical margins of ≥1 cm are recommended to minimize recurrence risk, and breast reconstruction should be considered as a delayed rather than immediate procedure, particularly for large malignant tumors that may require postoperative radiation, as suggested by the British Journal of Cancer and the National Comprehensive Cancer Network guidelines 4, 1